サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1479792

完全人工心臓のパイプライン - 開発段階、セグメント、地域と国、規制経路、主要企業（2024年版）

Total Artificial Heart Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

出版日
発行
GlobalData
ページ情報
英文 75 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
完全人工心臓のパイプライン - 開発段階、セグメント、地域と国、規制経路、主要企業（2024年版）
出版日: 2024年04月29日
発行: GlobalData
ページ情報: 英文 75 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、完全人工心臓のパイプライン製品について調査分析し、さまざまな開発段階にある製品の比較分析や、進行中の臨床試験のデータを含む、包括的な情報を提供しています。

目次

第1章 目次

第2章 イントロダクション

第3章 開発中の製品

  • 完全人工心臓 - パイプライン製品：開発段階別
  • 完全人工心臓 - パイプライン製品：地域別
  • 完全人工心臓 - パイプライン製品：規制経路別
  • 完全人工心臓 - パイプライン製品：推定承認日別
  • 完全人工心臓 - 進行中の臨床試験

第4章 完全人工心臓 - 開発中のパイプライン製品：企業別

  • 完全人工心臓企業 - パイプライン製品：開発段階別
  • 完全人工心臓 - パイプライン製品：開発段階別

第5章 完全人工心臓企業と製品の概要

  • Abiomed Inc：企業の概要
    • Abiomed Inc：パイプライン製品と進行中の臨床試験の概要
  • Aerospace Taixin Technology Co Ltd：企業の概要
    • Aerospace Taixin Technology Co Ltd：パイプライン製品と進行中の臨床試験の概要
  • BioLife4D Corp：企業の概要
    • BioLife4D Corp：パイプライン製品と進行中の臨床試験の概要
  • BiVacor Pty Ltd：企業の概要
    • BiVacor Pty Ltd：パイプライン製品と進行中の臨床試験の概要
  • Carmat SAS：企業の概要
    • Carmat SAS：パイプライン製品と進行中の臨床試験の概要
  • Cleveland Clinic Lerner College of Medicine：企業の概要
    • Cleveland Clinic Lerner College of Medicine：パイプライン製品と進行中の臨床試験の概要
  • Cleveland Heart Inc：企業の概要
    • Cleveland Heart Inc：パイプライン製品と進行中の臨床試験の概要
  • Collplant Biotechnologies Ltd：企業の概要
    • Collplant Biotechnologies Ltd：パイプライン製品と進行中の臨床試験の概要
  • CoRISMA MCS Systems Inc：企業の概要
    • CoRISMA MCS Systems Inc：パイプライン製品と進行中の臨床試験の概要
  • Foster-Miller Inc（休止中）：企業の概要
    • Foster-Miller Inc（休止中）：パイプライン製品と進行中の臨床試験の概要
  • Griffith University：企業の概要
    • Griffith University：パイプライン製品と進行中の臨床試験の概要
  • Lausanne University Hospital：企業の概要
    • Lausanne University Hospital：パイプライン製品と進行中の臨床試験の概要
  • OregonHeart Inc（休止中）：企業の概要
    • OregonHeart Inc（休止中）：パイプライン製品と進行中の臨床試験の概要
  • ReliantHeart, Inc.：企業の概要
    • ReliantHeart, Inc.：パイプライン製品と進行中の臨床試験の概要
  • Scandinavian Real Heart AB：企業の概要
    • Scandinavian Real Heart AB：パイプライン製品と進行中の臨床試験の概要
  • Shanghai Xinhengrui Medical Technology Co Ltd：企業の概要
    • Shanghai Xinhengrui Medical Technology Co Ltd：パイプライン製品と進行中の臨床試験の概要
  • Suzhou Xinqing Medical Technology Co Ltd：企業の概要
    • Suzhou Xinqing Medical Technology Co Ltd：パイプライン製品と進行中の臨床試験の概要
  • Syncardia Systems LLC：企業の概要
    • Syncardia Systems LLC：パイプライン製品と進行中の臨床試験の概要
  • University of New South Wales：企業の概要
    • University of New South Wales：パイプライン製品と進行中の臨床試験の概要
  • University of Tokyo：企業の概要
    • University of Tokyo：パイプライン製品と進行中の臨床試験の概要

第6章 完全人工心臓 - 近年の発展

第7章 付録

図表

List of Tables

  • Total Artificial Heart - Pipeline Products by Stage of Development
  • Total Artificial Heart - Pipeline Products by Territory
  • Total Artificial Heart - Pipeline Products by Regulatory Path
  • Total Artificial Heart - Pipeline Products by Estimated Approval Date
  • Total Artificial Heart - Ongoing Clinical Trials
  • Total Artificial Heart Companies - Pipeline Products by Stage of Development
  • Total Artificial Heart - Pipeline Products by Stage of Development
  • Abiomed Inc Pipeline Products & Ongoing Clinical Trials Overview
  • AbioCor II - Product Status
  • AbioCor II - Product Description
  • Aerospace Taixin Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • HeartCon II - Product Status
  • HeartCon II - Product Description
  • BioLife4D Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Mini-Heart - Product Status
  • Mini-Heart - Product Description
  • Viable Heart - Product Status
  • Viable Heart - Product Description
  • BiVacor Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • BiVACOR Device - Product Status
  • BiVACOR Device - Product Description
  • BiVacor Pty Ltd - Ongoing Clinical Trials Overview
  • BiVACOR Device - BiVACOR Total Artificial Heart Early Feasibility Study
  • Carmat SAS Pipeline Products & Ongoing Clinical Trials Overview
  • Aeson - Product Status
  • Aeson - Product Description
  • Carmat SAS - Ongoing Clinical Trials Overview
  • Aeson - Multicentric Prospective Cohort Study in Patients with Irreversible Biventricular Heart Failure to Assess the Efficacy and Safety of Carmat TAH, Its Clinical Utility and Cost, as a Bridge to Transplantation
  • Cleveland Clinic Lerner College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
  • Continuous-Flow Total Artificial Heart - Product Status
  • Continuous-Flow Total Artificial Heart - Product Description
  • Pediatric Continuous-Flow Total Artificial Heart - Product Status
  • Pediatric Continuous-Flow Total Artificial Heart - Product Description
  • Cleveland Heart Inc Pipeline Products & Ongoing Clinical Trials Overview
  • SmartHeart TAH - Product Status
  • SmartHeart TAH - Product Description
  • Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 3D Printed Heart - Product Status
  • 3D Printed Heart - Product Description
  • CoRISMA MCS Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • CoRISMA - Product Status
  • CoRISMA - Product Description
  • Foster-Miller Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Magscrew Total Artificial Heart - Product Status
  • Magscrew Total Artificial Heart - Product Description
  • Griffith University Pipeline Products & Ongoing Clinical Trials Overview
  • Next Generation Artificial Heart - Product Status
  • Next Generation Artificial Heart - Product Description
  • Lausanne University Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • RollingHeart - Product Status
  • RollingHeart - Product Description
  • OregonHeart Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Next Generation Total Artificial Heart - Product Status
  • Next Generation Total Artificial Heart - Product Description
  • ReliantHeart, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Pulse Less Total Artificial Heart - Product Status
  • Pulse Less Total Artificial Heart - Product Description
  • Scandinavian Real Heart AB Pipeline Products & Ongoing Clinical Trials Overview
  • Realheart TAH - Product Status
  • Realheart TAH - Product Description
  • Total Artificial Heart - Clinical Version - Product Status
  • Total Artificial Heart - Clinical Version - Product Description
  • Shanghai Xinhengrui Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Total Artificial Heart - Product Status
  • Total Artificial Heart - Product Description
  • Suzhou Xinqing Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • MoyoAssist - Product Status
  • MoyoAssist - Product Description
  • NyokAssist Percutaneous VAD - Product Status
  • NyokAssist Percutaneous VAD - Product Description
  • Syncardia Systems LLC Pipeline Products & Ongoing Clinical Trials Overview
  • SynCardia 50cc Temporary Total Artificial Heart - Destination Therapy - Product Status
  • SynCardia 50cc Temporary Total Artificial Heart - Destination Therapy - Product Description
  • SynCardia 70cc Temporary Total Artificial Heart - Destination Therapy - Product Status
  • SynCardia 70cc Temporary Total Artificial Heart - Destination Therapy - Product Description
  • University of New South Wales Pipeline Products & Ongoing Clinical Trials Overview
  • Total Artificial Heart - Product Status
  • Total Artificial Heart - Product Description
  • University of Tokyo Pipeline Products & Ongoing Clinical Trials Overview
  • Helical Flow Total Artificial Heart - Product Status
  • Helical Flow Total Artificial Heart - Product Description
  • Glossary

List of Figures

  • Total Artificial Heart - Pipeline Products by Stage of Development
  • Total Artificial Heart - Pipeline Products by Territory
  • Total Artificial Heart - Pipeline Products by Regulatory Path
  • Total Artificial Heart - Pipeline Products by Estimated Approval Date
  • Total Artificial Heart - Ongoing Clinical Trials
目次
Product Code: GDME1732EPD

GlobalData's Medical Devices sector report, "Total Artificial Heart Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Total Artificial Heart pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A Total Artificial Heart is a prosthetic device that is implanted into the body to replace the biological heart.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Total Artificial Heart under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Total Artificial Heart and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Total Artificial Heart under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Total Artificial Heart Overview

3 Products under Development

  • 3.1 Total Artificial Heart - Pipeline Products by Stage of Development
  • 3.2 Total Artificial Heart - Pipeline Products by Territory
  • 3.3 Total Artificial Heart - Pipeline Products by Regulatory Path
  • 3.4 Total Artificial Heart - Pipeline Products by Estimated Approval Date
  • 3.5 Total Artificial Heart - Ongoing Clinical Trials

4 Total Artificial Heart - Pipeline Products under Development by Companies

  • 4.1 Total Artificial Heart Companies - Pipeline Products by Stage of Development
  • 4.2 Total Artificial Heart - Pipeline Products by Stage of Development

5 Total Artificial Heart Companies and Product Overview

  • 5.1 Abiomed Inc Company Overview
    • 5.1.1 Abiomed Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Aerospace Taixin Technology Co Ltd Company Overview
    • 5.2.1 Aerospace Taixin Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 BioLife4D Corp Company Overview
    • 5.3.1 BioLife4D Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 BiVacor Pty Ltd Company Overview
    • 5.4.1 BiVacor Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Carmat SAS Company Overview
    • 5.5.1 Carmat SAS Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 Cleveland Clinic Lerner College of Medicine Company Overview
    • 5.6.1 Cleveland Clinic Lerner College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Cleveland Heart Inc Company Overview
    • 5.7.1 Cleveland Heart Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Collplant Biotechnologies Ltd Company Overview
    • 5.8.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 CoRISMA MCS Systems Inc Company Overview
    • 5.9.1 CoRISMA MCS Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 Foster-Miller Inc (Inactive) Company Overview
    • 5.10.1 Foster-Miller Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 Griffith University Company Overview
    • 5.11.1 Griffith University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Lausanne University Hospital Company Overview
    • 5.12.1 Lausanne University Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 OregonHeart Inc (Inactive) Company Overview
    • 5.13.1 OregonHeart Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 ReliantHeart, Inc. Company Overview
    • 5.14.1 ReliantHeart, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 Scandinavian Real Heart AB Company Overview
    • 5.15.1 Scandinavian Real Heart AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 Shanghai Xinhengrui Medical Technology Co Ltd Company Overview
    • 5.16.1 Shanghai Xinhengrui Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 Suzhou Xinqing Medical Technology Co Ltd Company Overview
    • 5.17.1 Suzhou Xinqing Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 Syncardia Systems LLC Company Overview
    • 5.18.1 Syncardia Systems LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 University of New South Wales Company Overview
    • 5.19.1 University of New South Wales Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 University of Tokyo Company Overview
    • 5.20.1 University of Tokyo Pipeline Products & Ongoing Clinical Trials Overview

6 Total Artificial Heart- Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer